Gastroenterology Abstracts On The Go
Claim This Podcastby University of Connecticut
Podcast Overview
<p>A monthly deep dive into the most influential and practice-shaping publications in Gastroenterology. Each episode breaks down key studies, highlights clinical implications, and offers clear, evidence-based insights for busy clinicians, trainees, and researchers. Whether it’s landmark trials, emerging therapies, or updated guidelines, this podcast brings the latest GI literature to life—helping listeners stay current, think critically, and apply new knowledge at the bedside.</p>
Language
🇺🇲
Publishing Since
12/5/2025
1 verified contact email on file for Gastroenterology Abstracts On The Go
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
March 24, 2026
Gastroenterology April 2026 Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease
<p>This study evaluates how effectively a specific blood biomarker, phosphatidylethanol (PEth), can forecast severe liver complications in individuals at risk for alcohol-related liver disease. While traditional noninvasive tests primarily measure existing liver scarring or fibrosis, this research demonstrates that tracking PEth levels provides a distinct, independent layer of prognostic data regarding a patient's future health. Although the predictive accuracy of a single PEth measurement fades over time, the study highlights that monitoring changes in alcohol intakethrough repeated testing is a powerful tool for identifying those most likely to experience hepatic failure. Ultimately, the findings suggest that integrating this chemical marker with standard physical assessments offers a more comprehensive view of disease progression than using either method in isolation.</p>
March 24, 2026
Gastroenterology April 2026 Genetic Risk of Inflammatory Bowel Disease Is Associated With Disease Course Severity
<p>This study investigates whether a person’s inherited predisposition to inflammatory bowel disease (IBD) also determines how aggressively the condition will progress. By analyzing thousands of patients, researchers found that individuals with a higher genetic burden faced significantly more hospitalizations, surgeries, and a greater need for intensive drug therapies. While the severity of Crohn’s disease was often linked to how much of the digestive tract was affected, ulcerative colitis showed a more direct shared genetic architecture between developing the disease and experiencing its most debilitating symptoms. Ultimately, the findings suggest that the same DNA markers used to predict the risk of IBD can also serve as a vital tool for forecasting a patient's long-term clinical outcome.</p>
March 24, 2026
Gastroenterology April 2026 Faecalibacterium prausnitzii Induces an Anti-inflammatory Response and a Metabolic Reprogramming in Human Monocytes
<p>This study explores how a common gut bacterium, Faecalibacterium prausnitzii, protects human health by directly influencing immune cells to reduce inflammation. Researchers discovered that this specific microbe triggers a dose-dependent production of IL10, a vital anti-inflammatory signal, within monocytes located in both the blood and the intestines. Unlike other bacteria, F. prausnitzii achieves this effect by rewiring the metabolic pathways of these cells, specifically by shifting their reliance toward mitochondrial respiration. By providing a mechanistic explanation for how this bacterium stabilizes the immune system, the text highlights its potential as a therapeutic tool for treating inflammatory bowel disease</p>
51 total episodes available
Deep-dive analytics for Gastroenterology Abstracts On The Go
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Gastroenterology Abstracts On The Go?
<p>A monthly deep dive into the most influential and practice-shaping publications in Gastroenterology. Each episode breaks down key studies, highlights clinical implications, and offers clear, evidence-based insights for busy clinicians, trainees, and researchers. Whether it’s landmark trials, emerging therapies, or updated guidelines, this podcast brings the latest GI literature to life—helping listeners stay current, think critically, and apply new knowledge at the bedside.</p> - How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.